A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD

Respiratory Medicine

Volumn 101, Issue 12, 2007, Pages 2472-2481

  Hutchinson, Anastasia F ^a,b,c   Ghimire, Anil K ^a   Thompson, Michelle A ^a,d   Black, Jim F ^c   Brand, Caroline A ^b   Lowe, Adrian J ^b   Smallwood, David M ^a   Vlahos, Ross ^d   Bozinovski, Steven ^d   Brown, Graham V ^c   Anderson, Gary P ^d   Irving, Louis B ^a  

^a Department of Respiratory Medicine ^*  (Australia)

^b Melbourne Health   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Lung diseases: obstructive; Respiratory tract infections; Respiratory viruses

Indexed keywords

ADENOVIRUS; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY CARE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NOSE SMEAR; PARAINFLUENZA VIRUS; PICORNAVIRUS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; THROAT CULTURE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS ISOLATION; VIRUS PNEUMONIA;

ACUTE DISEASE; ADENOVIRUSES, HUMAN; AGED; ANTIBODIES, VIRAL; COMMON COLD; COMMUNITY-ACQUIRED INFECTIONS; EPIDEMIOLOGIC METHODS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INFLUENZA A VIRUS; MALE; MIDDLE AGED; PICORNAVIRIDAE; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS; VIRUS DISEASES;

EID: 35448950448     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.07.015     Document Type: Article

References (58)

1. Pauwels R.A., and Rabe K.F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364 (2004) 613-619
2. Seemungal T.A., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., and Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1418-1422
3. Donaldson G.C., Seemungal T.A., Bhowmik A., and Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57 (2002) 847-852
4. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., and Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. J Am Med Assoc 283 (2000) 499-505
5. Miravitilles M., Murio C., Guerrero T., and Gisbert R. DAFNE Study Group Pharmaco-economic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121 (2002) 1449-1455
6. Hilleman D.E., Dewan N., Malesker M., and Friedman M. Pharmacoeconomic evaluation of COPD. Chest 118 (2000) 1278-1285
7. Strassels S. The costs of treating COPD in the United States. Chest 119 (2001) 344-352
8. Sethi S., and Murphy T.F. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 14 (2001) 336-363
9. Pope C.A. What do epidemiologic findings tell us about health effects of environmental aerosols. J Aeorsol Med 13 (2000) 335-354
10. Tillie-Leblond I., Marquette C.H., et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 144 (2006) 390-396
11. Rohde G., Wiethege A., Borg I., Kauth M., Bauer T.T., Gillissen A., et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58 (2003) 37-42
12. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1618-1623
13. Papi A., Bellettato M., Braccioni F., Romagnoli M., Casolari P., Caramori G., et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173 (2006) 1114-1121
14. Hurst J.R., Wilkinson T.M.A., Perera W.R., and Wedzicha J.A. Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 26 (2005) 846-852
15. Brand P.L., Quanjer Ph.H., and Postma D.S. Interpretation of bronchodilator response in patients with chronic obstructive airways disease. Thorax 47 (1992) 429-436
16. American Thoracic Society. COPD guidelines: 〈www.thoracic.org〉. In: ATS, 2005.
17. Anthonisen N.R., Manfreda J., Warren C.P.W., Hershfield E.S., Harding G.K.M., and Nelson N.A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary Disease. Ann Intern Med 106 (1987) 196-204
18. Burge S., and Wedzicha J.A. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 41 (2003) 46s-53s
19. Enright P.L. The six-minute walk test. Respir Care 48 (2003) 783-785
20. Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., and Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54 (1999) 581-586
21. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Eng J Med 350 (2004) 1005-1012
22. Druce J., Tran T., Kelly H., Kaye M., Chibo D., Kostecki R., et al. Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. J Med Virol 75 (2005) 122-129
23. In: Rose N.R., De MacArio E.C., Folds J.D., Lane H.C., and Nakanura R.M. (Eds). Manual of clinical laboratory immunology (1997), ASM Press, Washington, DC
24. Grist N.R., Ross C.A.C., Bell E.J., and Stott E.J. Diagnostic methods in clinical virology (1966), Blackwell distributed by Lippioncott, J.B., Oxford 54-71 [Chapter 6]
25. Ambrosino N., and Scano G. Dyspnoea and its measurement. Breathe 1 (2004) 101-107
26. Selim A.J., Ren X.S., Fincke G., Rogers W., Lee A., and Kazis L. A symptom-based measure of the severity of chronic lung disease*. Results from the Veterans Health Study. Chest 111 (1997) 1607-1614
27. Boivin G., Hardy I., Tellier G., and Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 31 (2000) 1166-1169
28. Gwaltney Jr. J.M., Hendley J.O., and Patrie J.T. Symptom severity patterns in experimental common colds and their usefulness in timing onset of illness in natural colds. Clin Infect Dis 36 (2003) 714-723
29. Monto A.S., Bramley T.J., and Sarnes M. Development of a predictive index for picornavirus infections. Clin Infect Dis 36 (2003) 253-258
30. Monto A.S., Gravenstein S., Elliott M., Colopy M., and Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 160 (2000) 3243-3247
31. Neuzil K.M., O'Connor T.Z., Gorse G.J., and Nichol K.L. Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine. Clin Infect Dis 36 (2003) 169-174
32. Norman D.C. Fever in the elderly. Clin Infect Dis 31 (2000) 148-151
33. Roghmann M.C., Warner J., and Mackowiak P.A. The relationship between age and fever magnitude. Am J Med Sci 322 (2001) 68-70
34. Sackett D.L., Haynes R.B., Guyatt G.H., and Tugwell P. Clinical epidemiology. A basic science for clinical medicine. 2nd ed (1991), Little, Brown and Company, Boston/Toronto/London
35. Statacorp. Stata statistical software release 8.2 (2003), Stata Corporation, College Station Texas
36. Fouchier R.A.M., Rimmelzwaan G.F., Kuiken T., and Osterhaus A.D.E. Newer respiratory virus infections: human metapneumovirus, avian influenza virus and human coronaviruses. Curr Opin Infect Dis 18 (2005) 141-146
37. Bastein N., Brandt K., Dust K., Ward D., and Li Y. Human Bocavirus infection, Canada. Emerging Infect Dis 12 (2006) 848-850
38. Fredricks D.N., and Relman D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 9 (1996) 18-33
39. Martinello R.A., Esper F., Weibel C., Ferguson D., Landry M.L., and Kahn J.S. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infection 53 (2005) 248-254
40. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., and Andersson B. Cloning of a human parvovirus by molecular screening of respiratory samples. PNAS 102 (2005) 12891-12896
41. Tan W.C., Xiang X., Qiu D., Ng T.P., Lam S.F., and Hegele R.G. Epidemiology of respiratory viruses in patients hospitalised with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 115 (2003) 272-277
42. Beckham J., Cadena A., Lin J., Piedra P.A., Glezen W.P., Greenberg S.B., et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 50 (2005) 322-330
43. Seemungal T.A., Harper-Owen R., Bhowmik A., Jeffries D.J., and Wedzicha J.A. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 16 (2000) 677-683
44. Rohde G. Relevance of human metapneumovirus in exacerbations of COPD. Respir Res 6 (2005) 150
45. Falsey A.R., Formica M.A., Hennessey P.A., Criddle M.M., Sullender W.M., and Walsh E.E. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 (2006) 639-643
46. Greenberg S.B. Respiratory viral infections in high-risk patients. Am J Respir Crit Care Med 170 (2004) 1142-1143
47. Victorian Infectious Diseases Laboratory (VIDRL). Fortnightly surveillance reports 〈〉, 2005.
48. Turner J.L., Fielding J.E., Clothier H.J., and Kelly H.A. Influenza surveillance in Victoria, 2005. Commun Dis Intell 30 (2005) 137-143
49. Kidney J., McManus T., and Coyle P.V. Exacerbations of chronic obstructive pulmonary disease. Thorax 57 (2002) 753-754
50. McManus T.E., Coyle P.V., and Kidney J.C. Childhood respiratory infections and hospital admissions for COPD. Respir Med 3 (2006) 512-518
51. Zambon M., Stockton J., Clewley J., and Fleming D. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 358 9291 (2001) 1410-1416
52. Peltola V.T., and Mccullers J. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 23 (2004) S87-S97
53. Engelich G., White M., and Hartshorn K.L. Role of the respiratory burst in so-operative reduction in neutrophil survival by influenza A virus and Escherichia coli. J Med Microbiol 51 (2002) 484-490
54. Smith C.B., Golden C., Klauber M.R., Kanner R., and Renzetti A. Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 134 (1976) 552-561
55. Avadhanula V., Rodriguez C.A., De Vincenzo J.P., Wang Y., Webby R.J., Ulett G.C., et al. Respiratory viruses augment adhesion of bacterial pathogens to respiratory epithelium in a viral-species and cell type dependent manner. J Virol 80 (2005) 1629-1636
56. Wilkinson T.M., Hurst J.R., Perera W.R., Wilks M., Donaldson G., and Wedzicha J.A. Effect of interactions between lower airway bacterial and rhinovirus infection in exacerbations of COPD. Chest 129 (2006) 317-324
57. Wilkinson T.M.A., Donaldson G.C., Hurst J.R., Seemungal T.A.R., and Wedzicha J.A. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169 (2004) 1298-1303
58. Remero J.R. Pleconaril: a novel anti-picornaviral drug. Expert Opin Investigat Drugs 10 (2001) 369-379